Engineering Porous Particles of Water Soluble Therapeutics for Pressurized Metered-dose Inhaler Formulations
The subject matter disclosed herein relates to methods for engineering porous particles of water soluble therapeutics with enhanced physical stability and aerosol characteristics in hydrofluoroalkane (HFA)-based pressurized metered-dose inhaler (pMDI) formulations.
DA ROCHA SANDRO RP [US]; WU LIBO [US]
Type of Offer:
« More Biotech Patents